NZ505834A - Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their use - Google Patents
Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their useInfo
- Publication number
- NZ505834A NZ505834A NZ505834A NZ50583498A NZ505834A NZ 505834 A NZ505834 A NZ 505834A NZ 505834 A NZ505834 A NZ 505834A NZ 50583498 A NZ50583498 A NZ 50583498A NZ 505834 A NZ505834 A NZ 505834A
- Authority
- NZ
- New Zealand
- Prior art keywords
- methods
- vaccae
- compositions containing
- delipidated
- containing polypeptides
- Prior art date
Links
- 241000187644 Mycobacterium vaccae Species 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 2
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 abstract 1
- 229920000189 Arabinogalactan Polymers 0.000 abstract 1
- 239000001904 Arabinogalactan Substances 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 235000019312 arabinogalactan Nutrition 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99662497A | 1997-12-23 | 1997-12-23 | |
| US08/997,080 US5968524A (en) | 1997-12-23 | 1997-12-23 | Methods and compounds for the treatment of immunologically-mediated psoriasis |
| US08/997,362 US5985287A (en) | 1996-08-29 | 1997-12-23 | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US09/095,855 US6160093A (en) | 1996-08-29 | 1998-06-11 | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US15618198A | 1998-09-17 | 1998-09-17 | |
| US09/205,426 US6406704B1 (en) | 1996-08-29 | 1998-12-04 | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| PCT/NZ1998/000189 WO1999032634A2 (en) | 1997-12-23 | 1998-12-23 | Compositions derived from mycobacterium vaccae and methods for their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ505834A true NZ505834A (en) | 2002-12-20 |
Family
ID=27557521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ505834A NZ505834A (en) | 1997-12-23 | 1998-12-23 | Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their use |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1044273A2 (zh) |
| JP (1) | JP2002514385A (zh) |
| CN (1) | CN1294632A (zh) |
| AU (1) | AU746311B2 (zh) |
| BR (1) | BR9814432A (zh) |
| CA (1) | CA2315539A1 (zh) |
| HU (1) | HUP0100352A2 (zh) |
| ID (1) | ID26327A (zh) |
| IL (1) | IL136821A0 (zh) |
| MX (1) | MXPA00006168A (zh) |
| NO (1) | NO20003261L (zh) |
| NZ (1) | NZ505834A (zh) |
| PL (1) | PL341697A1 (zh) |
| TR (1) | TR200001948T2 (zh) |
| WO (1) | WO1999032634A2 (zh) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6569436B1 (en) | 1998-10-05 | 2003-05-27 | The Malaghan Institute Of Medical Research | Method of using a vaccine |
| JP4415200B2 (ja) * | 1999-01-29 | 2010-02-17 | 大塚製薬株式会社 | 遅発育性抗酸菌ポリペプチド |
| GB9903539D0 (en) * | 1999-02-16 | 1999-04-07 | Stanford Rook Ltd | Therapy using M.Vaccae |
| US6350457B1 (en) * | 1999-06-02 | 2002-02-26 | Genesis Research & Development Corporation Limited | Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| BR0012740A (pt) * | 1999-07-12 | 2002-05-28 | Genesis Res & Dev Corp Ltd | Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego |
| CA2381139A1 (en) * | 1999-08-31 | 2001-03-08 | Michael Niederweis | Method for the production of a channel forming protein |
| NZ517409A (en) | 1999-08-31 | 2004-05-28 | Novozymes As | RP-II properties with amino acid substitutions used in detergent compositions and additives |
| US7217554B2 (en) | 1999-08-31 | 2007-05-15 | Novozymes A/S | Proteases and variants thereof |
| US6361776B1 (en) * | 1999-12-06 | 2002-03-26 | Genesis Research & Development Corp. Ltd. | Compounds isolated from M. vaccae and their use in modulation of immune responses |
| WO2001048154A1 (fr) * | 1999-12-28 | 2001-07-05 | Toyoshima, Kumao | Agent de maturation pour cellules dendritiques immatures |
| AUPQ761200A0 (en) * | 2000-05-19 | 2000-06-15 | Hunter Immunology Limited | Compositions and methods for treatment of mucosal infections |
| WO2002094184A2 (en) * | 2001-05-11 | 2002-11-28 | Corixa Corporation | Vaccines for the treatment of autoimmune disease |
| US20030147861A1 (en) * | 2001-07-26 | 2003-08-07 | Genesis Research And Development Corporation Limited | Compounds and methods for the modulation of immune responses |
| WO2003049751A1 (en) * | 2001-12-10 | 2003-06-19 | Bakulesh Mafatlal Khamar | The process of manufacturing a pharmaceutical composition useful for management of cancer |
| GB0303507D0 (en) * | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
| US10765731B2 (en) * | 2014-01-09 | 2020-09-08 | Transgene Sa | Fusion of heterooligomeric mycobacterial antigens |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8919321D0 (en) * | 1989-08-25 | 1989-10-11 | Univ London | Treatment of chronic inflammatory conditions |
| GB9203814D0 (en) * | 1992-02-21 | 1992-04-08 | Univ London | Treatment of long term auto-immune conditions |
| US6284255B1 (en) * | 1996-08-29 | 2001-09-04 | Genesis Research & Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
-
1998
- 1998-12-23 WO PCT/NZ1998/000189 patent/WO1999032634A2/en not_active Application Discontinuation
- 1998-12-23 CA CA002315539A patent/CA2315539A1/en not_active Abandoned
- 1998-12-23 AU AU18936/99A patent/AU746311B2/en not_active Ceased
- 1998-12-23 CN CN98813781A patent/CN1294632A/zh active Pending
- 1998-12-23 BR BR9814432-4A patent/BR9814432A/pt not_active IP Right Cessation
- 1998-12-23 ID IDW20001433A patent/ID26327A/id unknown
- 1998-12-23 TR TR2000/01948T patent/TR200001948T2/xx unknown
- 1998-12-23 JP JP2000525553A patent/JP2002514385A/ja active Pending
- 1998-12-23 MX MXPA00006168A patent/MXPA00006168A/es unknown
- 1998-12-23 IL IL13682198A patent/IL136821A0/xx unknown
- 1998-12-23 HU HU0100352A patent/HUP0100352A2/hu unknown
- 1998-12-23 NZ NZ505834A patent/NZ505834A/xx unknown
- 1998-12-23 EP EP98963665A patent/EP1044273A2/en not_active Withdrawn
- 1998-12-23 PL PL98341697A patent/PL341697A1/xx unknown
-
2000
- 2000-06-22 NO NO20003261A patent/NO20003261L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU1893699A (en) | 1999-07-12 |
| NO20003261L (no) | 2000-08-22 |
| PL341697A1 (en) | 2001-04-23 |
| CN1294632A (zh) | 2001-05-09 |
| WO1999032634A3 (en) | 1999-12-02 |
| BR9814432A (pt) | 2000-10-10 |
| EP1044273A2 (en) | 2000-10-18 |
| TR200001948T2 (tr) | 2001-02-21 |
| HUP0100352A2 (hu) | 2001-06-28 |
| AU746311B2 (en) | 2002-04-18 |
| ID26327A (id) | 2000-12-14 |
| MXPA00006168A (es) | 2005-02-24 |
| NO20003261D0 (no) | 2000-06-22 |
| CA2315539A1 (en) | 1999-07-01 |
| IL136821A0 (en) | 2001-06-14 |
| JP2002514385A (ja) | 2002-05-21 |
| WO1999032634A2 (en) | 1999-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ505834A (en) | Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their use | |
| NZ333607A (en) | Method of stimulating the immune system by transfecting dendritic cells | |
| ATE314095T1 (de) | Virusähnliche partikel zur induktion von autoantikörpern | |
| WO1998055495A3 (en) | Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof | |
| WO1998033527A3 (en) | Cancer immunotherapy with semi-allogeneic cells | |
| IL141775A0 (en) | Aglyco products and methods of use | |
| HK1033582A1 (en) | Antibodies to death receptor 4 (dr4) and uses thereof | |
| WO1998008542A3 (en) | Compounds and methods for treatment and diagnosis of mycobacterial infections | |
| HK1142093A1 (zh) | 在細胞培養中複製流感病毒的方法以及可通過該方法獲得的流感病毒 | |
| HK1086750A1 (en) | Pharmaceutical composition for inducing an immune response in a human or animal | |
| PL332694A1 (en) | Purine l-nucleosides, their analoques and their application | |
| CA2033640A1 (en) | Vaccines against cancer and infectious diseases | |
| IL138424A (en) | Covalently reactive antigen analogs and pharmaceutical compositions containing the same | |
| WO1999003976A3 (en) | Method of treating leukocytes, leukocyte compositions and methods of use thereof | |
| WO1998039034A3 (de) | Verwendung von anti-cd44 antikörper enthaltenden präparationen zur behandlung bestimmter tumore und zur unterdrückung von immunreaktionen | |
| CA2232344A1 (en) | Compositions and methods for enhancing immune responses mediated by antigen-presenting cells | |
| GB2355983A (en) | Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class 1 molecule and an attaching means | |
| CA2064029A1 (en) | Use of mycobacterium vaccae in the prevention of aids | |
| EP0202642A3 (en) | Process for the in vitro immunization of human splenocytes against tumor associated antigens | |
| WO1999049876A3 (en) | Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof | |
| WO2001059073A3 (en) | Cytotoxic t lymphocytes activated by dendritic cell hybrids | |
| AU3929589A (en) | Human papilloma virus type 57, the dna thereof and the proteins encoded thereby | |
| AU617330B2 (en) | Human papillomavirus type 41, its DNA and the proteins encoded therefrom | |
| WO2000077177A3 (en) | Isolation of a human retrovirus | |
| EP1637166A3 (en) | Virus-like particles for the induction of autoantibodies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| PSEA | Patent sealed |